FIB-4 Index and Diabetes Mellitus Are Associated with Chronic Kidney Disease in Japanese Patients with Non-Alcoholic Fatty Liver Disease

被引:18
|
作者
Seko, Yuya [1 ]
Yano, Kohta [1 ]
Takahashi, Aya [1 ]
Okishio, Shinya [1 ]
Kataoka, Seita [1 ]
Okuda, Keiichiroh [1 ]
Mizuno, Naoki [1 ]
Takemura, Masashi [1 ]
Taketani, Hiroyoshi [1 ]
Umemura, Atsushi [1 ]
Nishikawa, Taichiro [1 ]
Yamaguchi, Kanji [1 ]
Moriguchi, Michihisa [1 ]
Okanoue, Takeshi [2 ]
Itoh, Yoshito [1 ]
机构
[1] Kyoto Prefectural Univ Med, Dept Mol Gastroenterol & Hepatol, Kyoto 6028566, Japan
[2] Saiseikai Suita Hosp, Dept Gastroenterol & Hepatol, Osaka 5640013, Japan
关键词
nonalcoholic fatty liver disease; Type; 2; diabetes; Hepatic fibrosis; PNPLA3; RISK; POPULATION; MECHANISMS; OBESITY;
D O I
10.3390/ijms21010171
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Non-alcoholic fatty liver disease (NAFLD) is associated with chronic kidney disease (CKD). The aim of this retrospective study was to determine the risk factors for progression of CKD in patients with biopsy-proven NAFLD including patatin-like phospholipase domain containing 3 (PNPLA3) polymorphism. A total of 344 patients with biopsy-proven NAFLD were enrolled consecutively in this study. Multivariate analysis identified males (odds ratio (OR) 5.46), age (per 1 year, OR 1.07), and FIB-4 index (>= 1.30, OR 3.85) as factors associated with CKD. Of the 154 patients with a baseline estimated glomerular filtration rate (eGFR) >= 60 mL/min, 30 had a deterioration in CKD stage and 15 developed CKD after 3 years. Multivariate analysis identified diabetes mellitus (OR 2.44) as a risk factor for deterioration in CKD stage, while diabetes mellitus (OR 21.54) and baseline eGFR (per 1 mL/min OR 0.88) were risk factors for development of CKD. PNPLA3 did not affect the change in eGFR. In NAFLD patients, a high FIB-4 index was associated with CKD to increases in the index linked to reductions in eGFR. In order to prevent development of CKD, an appropriate therapy focusing on renal function is needed for NAFLD patients, especially those with diabetes.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Background of the FIB-4 Index in Japanese Non-Alcoholic Fatty Liver Disease
    Wada, Takashi
    Zeniya, Mikio
    INTERNAL MEDICINE, 2015, 54 (02) : 127 - 132
  • [2] The Development of Chronic Kidney Disease in Japanese Patients with Non-alcoholic Fatty Liver Disease
    Arase, Yasuji
    Suzuki, Fumitaka
    Kobayashi, Mariko
    Suzuki, Yoshiyuki
    Kawamura, Yusuke
    Matsumoto, Naoki
    Akuta, Norio
    Kobayashi, Masahiro
    Sezaki, Hitomi
    Saito, Satoshi
    Hosaka, Tetsuya
    Ikeda, Kenji
    Kumada, Hiromitsu
    Ohmoto, Yuki
    Amakawa, Kazuhisa
    Tsuji, Hiroshi
    Hsieh, Shiun Dong
    Kato, Kazuhisa
    Tanabe, Maho
    Ogawa, Kyoko
    Hara, Shigeko
    Kobayashi, Tetsuro
    INTERNAL MEDICINE, 2011, 50 (10) : 1081 - 1087
  • [3] Increased prevalence of chronic kidney disease in patients with Type 1 diabetes and non-alcoholic fatty liver
    Targher, G.
    Pichiri, I.
    Zoppini, G.
    Trombetta, M.
    Bonora, E.
    DIABETIC MEDICINE, 2012, 29 (02) : 220 - 226
  • [4] Ultrasonographic grayscale findings related to fibrosis in patients with non-alcoholic fatty liver disease: comparison with transient elastography and Fib-4 index
    Matsumoto, Naoki
    Kumagawa, Mariko
    Ogawa, Masahiro
    Kaneko, Masahiro
    Watanabe, Yukinobu
    Nakagawara, Hiroshi
    Masuzaki, Ryota
    Kanda, Tatsuo
    Moriyama, Mitsuhiko
    Sugitani, Masahiko
    JOURNAL OF MEDICAL ULTRASONICS, 2021, 48 (03) : 323 - 333
  • [5] Association between non-alcoholic fatty liver disease and chronic kidney disease in population with prediabetes or diabetes
    Li, Yongqiang
    Zhu, Shuangshuang
    Li, Bin
    Shao, Xiaofei
    Liu, Xinyu
    Liu, Aiqun
    Wu, Bifang
    Zhang, Ying
    Wang, Honglei
    Wang, Xiaohong
    Deng, Kangping
    Liu, Qin
    Huang, Min
    Liu, Hongmei
    Holthoefer, Harry
    Zou, Hequn
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2014, 46 (09) : 1785 - 1791
  • [6] Association Between the Risk of Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes and Chronic Kidney Disease
    Zhao, Pingping
    Yan, Junxin
    Pan, Binjing
    Liu, Jingfang
    Fu, Songbo
    Cheng, Jianguo
    Wang, Liting
    Jing, Gaojing
    Li, Qiong
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2022, 15 : 1141 - 1151
  • [7] Non-alcoholic fatty liver disease is associated with increased risk of chronic kidney disease
    Cai, Xiaoyan
    Sun, Lichang
    Liu, Xiong
    Zhu, Hailan
    Zhang, Yang
    Zheng, Sulin
    Huang, Yuli
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2021, 12
  • [8] High FIB-4 index as an independent risk factor of prevalent chronic kidney disease in patients with nonalcoholic fatty liver disease
    Xu, Huang-Wei
    Hsu, Yung-Chien
    Chang, Chia-Hao
    Wei, Kuo-Liang
    Lin, Chun-Liang
    HEPATOLOGY INTERNATIONAL, 2016, 10 (02) : 340 - 346
  • [9] Non-alcoholic fatty liver disease (NAFLD) is associated with an increased incidence of chronic kidney disease (CKD)
    Roderburg, Christoph
    Krieg, Sarah
    Krieg, Andreas
    Demir, Muenevver
    Luedde, Tom
    Kostev, Karel
    Loosen, Sven H.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2023, 28 (01)
  • [10] Non-alcoholic fatty liver disease and diabetes mellitus as growing aetiologies of hepatocellular carcinoma
    Talamantes, Stephanie
    Lisjak, Michela
    Gilglioni, Eduardo H.
    Llamoza-Torres, Camilo J.
    Ramos-Molina, Bruno
    Gurzov, Esteban N.
    JHEP REPORTS, 2023, 5 (09)